244 related articles for article (PubMed ID: 26888201)
21. [Effect of dihydroartemisinin at low concentration on intervention of Plasmodium falciparum 3D7 strain].
Guo Y; Li K; Jiang XH; Yang T; Zheng ZY; Chen LN; Li YJ; Zheng XJ
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(16):3397-3403. PubMed ID: 30200747
[TBL] [Abstract][Full Text] [Related]
22. The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.
Dembele L; Ang X; Chavchich M; Bonamy GMC; Selva JJ; Lim MY; Bodenreider C; Yeung BKS; Nosten F; Russell BM; Edstein MD; Straimer J; Fidock DA; Diagana TT; Bifani P
Sci Rep; 2017 May; 7(1):2325. PubMed ID: 28539634
[TBL] [Abstract][Full Text] [Related]
23. Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes.
Hott A; Casandra D; Sparks KN; Morton LC; Castanares GG; Rutter A; Kyle DE
Antimicrob Agents Chemother; 2015; 59(6):3156-67. PubMed ID: 25779582
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the use of heparin for synchronization of in vitro culture of Plasmodium falciparum.
Kobayashi K; Kato K
Parasitol Int; 2016 Oct; 65(5 Pt B):549-551. PubMed ID: 27600143
[TBL] [Abstract][Full Text] [Related]
25. Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay.
Rebelo M; Tempera C; Fernandes JF; Grobusch MP; Hänscheid T
Malar J; 2015 Apr; 14():140. PubMed ID: 25879757
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites.
Bullard KM; Broccardo C; Keenan SM
Malar J; 2015 Apr; 14():147. PubMed ID: 25879664
[TBL] [Abstract][Full Text] [Related]
27. New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum.
Lobo L; Cabral LIL; Sena MI; Guerreiro B; Rodrigues AS; de Andrade-Neto VF; Cristiano MLS; Nogueira F
Malar J; 2018 Apr; 17(1):145. PubMed ID: 29615130
[TBL] [Abstract][Full Text] [Related]
28. Restructured Mitochondrial-Nuclear Interaction in Plasmodium falciparum Dormancy and Persister Survival after Artemisinin Exposure.
Connelly SV; Manzella-Lapeira J; Levine ZC; Brzostowski J; Krymskaya L; Rahman RS; Ellis AC; Amin SN; Sá JM; Wellems TE
mBio; 2021 Jun; 12(3):e0075321. PubMed ID: 34044591
[TBL] [Abstract][Full Text] [Related]
29. Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay.
Walz A; Leroy D; Andenmatten N; Mäser P; Wittlin S
Malar J; 2019 Dec; 18(1):427. PubMed ID: 31849323
[TBL] [Abstract][Full Text] [Related]
30. Time course of in vitro maturation of intra-erythrocytic malaria parasite: a comparison between Plasmodium falciparum and Plasmodium knowlesi.
Srinivas SD; Puri SK
Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):901-3. PubMed ID: 12386719
[TBL] [Abstract][Full Text] [Related]
31. Refrigeration provides a simple means to synchronize in vitro cultures of Plasmodium falciparum.
Yuan L; Hao M; Wu L; Zhao Z; Rosenthal BM; Li X; He Y; Sun L; Feng G; Xiang Z; Cui L; Yang Z
Exp Parasitol; 2014 May; 140():18-23. PubMed ID: 24632190
[TBL] [Abstract][Full Text] [Related]
32. PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.
van der Velden M; Rijpma SR; Russel FG; Sauerwein RW; Koenderink JB
Malar J; 2015 Feb; 14():76. PubMed ID: 25884516
[TBL] [Abstract][Full Text] [Related]
33. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.
Xie SC; Dogovski C; Hanssen E; Chiu F; Yang T; Crespo MP; Stafford C; Batinovic S; Teguh S; Charman S; Klonis N; Tilley L
J Cell Sci; 2016 Jan; 129(2):406-16. PubMed ID: 26675237
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
Yang T; Xie SC; Cao P; Giannangelo C; McCaw J; Creek DJ; Charman SA; Klonis N; Tilley L
Antimicrob Agents Chemother; 2016 Aug; 60(8):4501-10. PubMed ID: 27161632
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate.
Baumgärtner F; Jourdan J; Scheurer C; Blasco B; Campo B; Mäser P; Wittlin S
Malar J; 2017 Jan; 16(1):45. PubMed ID: 28122617
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic based separation.
Spadafora C; Gerena L; Kopydlowski KM
Malar J; 2011 Apr; 10():96. PubMed ID: 21501476
[TBL] [Abstract][Full Text] [Related]
37. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the induction of dormant ring stages in Plasmodium falciparum parasites by artemisone and artemisone entrapped in Pheroid vesicles in vitro.
Grobler L; Chavchich M; Haynes RK; Edstein MD; Grobler AF
Antimicrob Agents Chemother; 2014 Dec; 58(12):7579-82. PubMed ID: 25288088
[TBL] [Abstract][Full Text] [Related]
39. Efficient synchronization of Plasmodium knowlesi in vitro cultures using guanidine hydrochloride.
Ngernna S; Chim-Ong A; Roobsoong W; Sattabongkot J; Cui L; Nguitragool W
Malar J; 2019 Apr; 18(1):148. PubMed ID: 31023359
[TBL] [Abstract][Full Text] [Related]
40. Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.
Bouillon A; Gorgette O; Mercereau-Puijalon O; Barale JC
Methods Mol Biol; 2013; 923():523-34. PubMed ID: 22990802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
